These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 23055279

  • 1. Enzymatic deglycosylation converts pathogenic neuromyelitis optica anti-aquaporin-4 immunoglobulin G into therapeutic antibody.
    Tradtrantip L, Ratelade J, Zhang H, Verkman AS.
    Ann Neurol; 2013 Jan; 73(1):77-85. PubMed ID: 23055279
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Therapeutic cleavage of anti-aquaporin-4 autoantibody in neuromyelitis optica by an IgG-selective proteinase.
    Tradtrantip L, Asavapanumas N, Verkman AS.
    Mol Pharmacol; 2013 Jun; 83(6):1268-75. PubMed ID: 23571414
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Recombinant IgG1 Fc hexamers block cytotoxicity and pathological changes in experimental in vitro and rat models of neuromyelitis optica.
    Tradtrantip L, Felix CM, Spirig R, Morelli AB, Verkman AS.
    Neuropharmacology; 2018 May 01; 133():345-353. PubMed ID: 29428821
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Involvement of antibody-dependent cell-mediated cytotoxicity in inflammatory demyelination in a mouse model of neuromyelitis optica.
    Ratelade J, Asavapanumas N, Ritchie AM, Wemlinger S, Bennett JL, Verkman AS.
    Acta Neuropathol; 2013 Nov 01; 126(5):699-709. PubMed ID: 23995423
    [Abstract] [Full Text] [Related]

  • 11. Inhibitor(s) of the classical complement pathway in mouse serum limit the utility of mice as experimental models of neuromyelitis optica.
    Ratelade J, Verkman AS.
    Mol Immunol; 2014 Nov 01; 62(1):104-13. PubMed ID: 24980869
    [Abstract] [Full Text] [Related]

  • 12. Human immunoglobulin G reduces the pathogenicity of aquaporin-4 autoantibodies in neuromyelitis optica.
    Ratelade J, Smith AJ, Verkman AS.
    Exp Neurol; 2014 May 01; 255():145-53. PubMed ID: 24636863
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A small-molecule screen yields idiotype-specific blockers of neuromyelitis optica immunoglobulin G binding to aquaporin-4.
    Phuan PW, Anderson MO, Tradtrantip L, Zhang H, Tan J, Lam C, Bennett JL, Verkman AS.
    J Biol Chem; 2012 Oct 26; 287(44):36837-44. PubMed ID: 22989877
    [Abstract] [Full Text] [Related]

  • 16. Neuromyelitis optica: aquaporin-4 based pathogenesis mechanisms and new therapies.
    Ratelade J, Verkman AS.
    Int J Biochem Cell Biol; 2012 Sep 26; 44(9):1519-30. PubMed ID: 22713791
    [Abstract] [Full Text] [Related]

  • 17. Membrane assembly of aquaporin-4 autoantibodies regulates classical complement activation in neuromyelitis optica.
    Soltys J, Liu Y, Ritchie A, Wemlinger S, Schaller K, Schumann H, Owens GP, Bennett JL.
    J Clin Invest; 2019 Apr 08; 129(5):2000-2013. PubMed ID: 30958797
    [Abstract] [Full Text] [Related]

  • 18. Neuromyelitis optica IgG does not alter aquaporin-4 water permeability, plasma membrane M1/M23 isoform content, or supramolecular assembly.
    Rossi A, Ratelade J, Papadopoulos MC, Bennett JL, Verkman AS.
    Glia; 2012 Dec 08; 60(12):2027-39. PubMed ID: 22987455
    [Abstract] [Full Text] [Related]

  • 19. Intravenous neuromyelitis optica autoantibody in mice targets aquaporin-4 in peripheral organs and area postrema.
    Ratelade J, Bennett JL, Verkman AS.
    PLoS One; 2011 Dec 08; 6(11):e27412. PubMed ID: 22076159
    [Abstract] [Full Text] [Related]

  • 20. Mutagenesis of the aquaporin 4 extracellular domains defines restricted binding patterns of pathogenic neuromyelitis optica IgG.
    Owens GP, Ritchie A, Rossi A, Schaller K, Wemlinger S, Schumann H, Shearer A, Verkman AS, Bennett JL.
    J Biol Chem; 2015 May 08; 290(19):12123-34. PubMed ID: 25792738
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.